Cadence Capital Management’s BioLife Solutions BLFS Stock Holding History

Cadence Capital Management’s Portfolio BLFS Stock Details BLFS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$610K	Sell	21,065 -41,125	-66%	-$888K	0.15%	113
2020 Q2	$1.02M	Buy	+62,190	New	+$857K	0.15%	213
2020 Q1	–	Sell	-60,688	Closed	-$982K	–	427
2019 Q4	$982K	Sell	60,688 -123,603	-67%	-$2.01M	0.11%	270
2019 Q3	$3.06M	Sell	184,291 -4,659	-2%	-$87.4K	0.43%	56
2019 Q2	$3.2M	Sell	188,950 -6,319	-3%	-$110K	0.32%	74
2019 Q1	$3.49M	Buy	195,269 +3,439	+2%	+$54.7K	0.31%	75
2018 Q4	$2.31M	Buy	191,830 +56,651	+42%	+$677K	0.23%	120
2018 Q3	$2.37M	Buy	+135,179	New	+$2.67M	0.13%	221

Other funds holding BLFS

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Cadence Capital Management's BLFS Position: Q3 2020 in Review

Cadence Capital Management reduced its BioLife Solutions (BLFS) stake by 66% in Q3 2020, selling an estimated $888K and leaving 21,065 shares worth $610K. The position accounts for 0.15% of the portfolio, ranked #113.

Cadence Capital Management first reported a position in BLFS in Q3 2018 and has held it in 8 quarters since. The position peaked at $3.49M in Q1 2019. 108 funds tracked by Wall St. Rank hold BLFS as of Q3 2020.

Cadence Capital Management held 21,065 shares of BioLife Solutions worth $610K as of Q3 2020.
Cadence Capital Management sold 41,125 BioLife Solutions shares in Q3 2020, an estimated $888K.
BioLife Solutions made up 0.15% of Cadence Capital Management's portfolio in Q3 2020, its #113 holding.
Cadence Capital Management first reported a position in BioLife Solutions in Q3 2018 and has held it in 8 quarters since.
Cadence Capital Management's BioLife Solutions position peaked at $3.49M in Q1 2019.
108 funds tracked by Wall St. Rank held BioLife Solutions as of Q3 2020.

Based on Cadence Capital Management's 13F filing for Q3 2020, filed 16 Oct 2020.